Related Experiment Video

Updated: Jun 19, 2026

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells

Alexey Tyryshkin1, F Murat Gorgun, Elmoataz Abdel Fattah

  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.

The Journal of Biological Chemistry
|October 31, 2009
PubMed

Insights

Src kinases regulate cell functions and are implicated in cancer. This study reveals that Src phosphorylates inducible nitric-oxide synthase (iNOS), stabilizing it and linking Src activity to inflammation and cancer progression.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • Src kinases are critical regulators of cellular processes, including proliferation, survival, and motility.
  • Aberrant Src activity is linked to inflammation and the development of various cancers, notably lung cancer.
  • Src inhibition is an emerging therapeutic strategy for non-small cell lung cancer.

Purpose of the Study:

  • To investigate the molecular mechanisms linking Src kinases to inflammation and cancer.
  • To identify downstream mediators of activated Src.
  • To elucidate the role of Src in regulating inducible nitric-oxide synthase (iNOS).

Main Methods:

  • Utilized models of inflammation (lipopolysaccharide/cytokines) and cancer cell lines/tissues.
  • Investigated the interaction and co-localization of Src and iNOS.
  • Identified specific phosphorylation sites on iNOS using biochemical assays.
  • Assessed iNOS half-life and nitric oxide production.

Main Results:

  • Inducible nitric-oxide synthase (iNOS) was identified as a direct downstream mediator of activated Src.
  • Src-mediated phosphorylation of human iNOS at residue Tyr(1055) was demonstrated.
  • Phosphorylation by Src was shown to stabilize iNOS protein half-life.
  • Interactions and co-localization of iNOS and activated Src were observed in inflammatory and cancer contexts.

Conclusions:

  • Src-mediated phosphorylation of iNOS is a key regulatory mechanism.
  • This posttranslational modification influences iNOS stability and nitric oxide production.
  • The Src-iNOS interaction provides insights into Src's roles in inflammation and cancer pathogenesis.

More Related Videos

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...